Implication of mitochondrial ROS-NLRP3 inflammasome axis during two-hit mediated acute lung injury in mice

Gayatri Puri1, Amarjit S Naura1

  • 1Department of Biochemistry, Panjab University, Chandigarh, India.

Free Radical Research
|February 7, 2022
PubMed

Insights

Acid aspiration combined with bacterial components exacerbates acute lung injury (ALI). Targeting mitochondrial ROS and NLRP3 inflammasome activation may combat ALI and ARDS.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Cellular Biology

Background:

  • Acid aspiration can cause acute lung injury (ALI), often worsened by bacterial components, leading to acute respiratory distress syndrome (ARDS).
  • The mechanisms behind this inflammation exacerbation, particularly involving the NLRP3 inflammasome and mitochondrial reactive oxygen species (mtROS), in a
  • two-hit
  • ALI model are not well understood.

Purpose of the Study:

  • To investigate the role of the mitochondrial ROS (mtROS)-NLRP3 inflammasome axis in
  • two-hit
  • (Hydrochloric acid + Lipopolysaccharide) induced ALI.

Main Methods:

  • Induction of
  • two-hit
  • ALI in mice.
  • Assessment of inflammatory cell infiltration in bronchoalveolar lavage fluid (BALF).
  • Measurement of mtROS using MitoSOX staining.
  • Evaluation of NLRP3 inflammasome activation (caspase-1, IL-1β).
  • Pharmacological inhibition of NLRP3 inflammasome (MCC950) and mtROS (Mito-tempo).
  • Analysis of NF-κB signaling pathway activation.

Main Results:

  • The
  • two-hit
  • model significantly aggravated lung inflammation compared to single insults.
  • Increased mtROS levels were observed in BALF neutrophils and macrophages.
  • Activated NLRP3 inflammasome, evidenced by increased active caspase-1 and IL-1β.
  • NLRP3 inhibition (MCC950) and mtROS scavenging (Mito-tempo) ameliorated lung inflammation.
  • Mito-tempo treatment reduced mtROS, NLRP3 activation, and downstream inflammatory gene expression (IL-1β, TNF-α, IL-6) via NF-κB inhibition.

Conclusions:

  • mtROS-mediated NLRP3 inflammasome activation is a critical driver of exaggerated inflammation in
  • two-hit
  • ALI.
  • Targeting the mtROS-NLRP3 inflammasome axis presents a promising therapeutic strategy for ALI and ARDS.

Related Concept Videos